Shanghai Yutong Pharma, Inc. Completes Definitive Merger with Child Vision, Inc.
16 July 2005 - 6:52AM
PR Newswire (US)
Shanghai Yutong Pharma, Inc. Completes Definitive Merger with Child
Vision, Inc. NEW YORK, July 15 /PRNewswire-FirstCall/ -- On July
1st, 2005 Shanghai Yutong Pharmaceuticals, Ltd completed its
definitive merger agreement with China Child Vision, Inc.
(OTC:SYUP) (BULLETIN BOARD: SYUP) The exchange of shares was
calculated at a ratio of 4 shares of Shanghai Yutong
Pharmaceuticals, Ltd for each one share of Child Vision, Inc. The
Board had also agreed to enact a 5 for 1 forward split of the stock
to all shareholders of record. To reflect the change of control,
the Board of Directors elected to change the name of the
Corporation to Shanghai Yutong Pharma, Inc. as well as the trading
symbol to SYUP. About Shanghai Yutong Pharma, Inc. Shanghai Yutong
Pharma, Inc through its subsidiary Shanghai Yutong Pharmaceuticals,
Ltd. develops Chinese herbal medicines and biological
pharmaceuticals using modern biotechnology and traditional Chinese
medical technology. Shanghai Yutong operates from a 90,000 square
foot GMP-approved facility and markets over 13 kinds of traditional
Chinese medicine with sales distribution in Hong Kong, Philippines,
Singapore and Taiwan. The Company's flagship product, Qilisheng
Oral Solution, has been granted a U.S. patent. Legal Disclaimer The
statements contained in this press release contain certain forward
looking statements, including statements regarding the company's
expectations, intentions, strategies and beliefs regarding the
future. All statements contained herein are based upon information
available to the company's management as of the date hereof, and
actual results may vary based upon future events, both within and
without the control of the company's management. For Further
Information: Rick Oravec 212-924-3548 DATASOURCE: Shanghai Yutong
Pharma, Inc. CONTACT: Rick Oravec, , +1-212-924-3548
Copyright